Cleaning & Odour Remover MSDS 51-11077 - Stain & Odour Remover | Page 2

MATERIAL SAFETY DATA SHEET: 11051-55 S&O Section V - Health and Hazard Data Threshold Limit Value: 200 PPM AS ISOPROPANOL 1. Effects of Overexposure: Acute: (Short Term Exposure) EYE CONTACT: CAUSES IRRITATION SEEN AS STINGING, TEARING, AND REDNESS. MAY CAUSE CORNEAL DAMAGE. SKIN CONTACT: MAY CAUSE IRRITATION SEEN AS ITCHING AND REDNESS. PROLONGED OR REPEATED CONTACT MAY CAUSE DRYING AND DEFATTING OF THE SKIN. PRODUCT MAY BE ABSORBED THROUGH THE SKIN IN HARMFUL AMOUNTS. INHALATION: CAUSES RESPIRATORY IRRITATION SEEN AS COUGHING AND SNEEZING. AT LOW VAPOR CONCENTRATIONS, NO HARMFUL EFFECTS ARE EXPECTED. AT HIGH VAPOR CONCENTRATIONS, INHALATION MAY CAUSE CENTRAL NERVOUS SYSTEM EFFECTS SUCH AS HEADACHE, DIZZINESS, DROWSINESS, WEAKNESS, UNCONCIOUSNESS, POSSIBLE ANESTHETIC EFFECTS FROM CENTRAL NERVOUS SYSTEM DEPRESSION, AND MAY BE FATAL. INGESTION: MAY CAUSE IRRITATION WITH POSSIBLE NAUSEA, VOMITING, DIARRHEA, AND CENTRAL NERVOUS SYSTEM EFFECTS SIMILAR TO INHALATION. Chronic: (Long Term Exposure) NO HUMAN CHRONIC EFFECTS KNOWN. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE ARE PRE-EXISTING RESPIRATORY AND SKIN CONDITIONS SUCH AS ASTHMA, EMPHYSEMA, AND DERMATITIS. TARGET ORGANS: CENTRAL NERVOUS SYSTEM. THE PRIMARY ROUTES OF EXPOSURE ARE SKIN AND EYE CONTACT. Primary Routes of Entry [√] Inhalation [ ] Ingestion [√] Absorption Emergency First Aid Procedures: Inhalation: REMOVE FROM THE AREA TO FRESH AIR. SEEK MEDICAL ATTENTION IF RESPIRATORY IRRITATION DEVELOPS OR IF BREATHING BECOMES DIFFICULT. Eye Contact: RINSE THE EYES WITH WATER. REMOVE ANY CONTACT LENSES AND CONTINUE FLUSHING WITH PLENTY OF WATER FOR SEVERAL MINUTES. SEEK MEDICAL ATTENTION IF IRRITATION DEVELOPS. Skin Contact: WASH AFFECTED AREAS WITH PLENTY OF SOAP AND WATER FOR SEVERAL MINUTES. SEEK MEDICAL ATTENTION IF IRRITATION DEVELOPS. Ingestion: GIVE 3 TO 4 GLASSES OF WATER, BUT DO NOT INDUCE VOMITING. IF VOMITING OCCURS, GIVE FLUIDS AGAIN. SEEK MEDICAL ATTENTION IF DISCOMFORT OCCURS. Notes to Physician: THERE IS NO SPECIFIC ANTIDOTE. TREAT THE PATIENT SYMPTOMATICALLY. Section VI - Toxicity Information Product Contains Chemicals Listed as Carcinogen or Potential Carcinogen By: [ ] IARC [ ] NTP [ ] OSHA [ ] ACGIH [ ] Other VOC CONTENT: 2.6% BY WEIGHT; 3.3% BY VOLUME; 25.9 G/L ISOPROPANOL IHL-RAT LC50: 16000 PPM/8H 3. ORL-HMN LDLo: 3570 MG/KG 3. ORL-RAT LD50: 5045 MG/KG 3. SKN-RBT LD50: 12800 MG/KG 3. SKN-RBT-SDT: 500 MG MILD 3. EYE-RBT-SDT: 10 MG MODERATE 3. Section VII - Reactivity Data Stability [√] Stable Hazardous Polymerization [ ] Unstable Conditions to Avoid: AVOID HEAT, HOT SURFACES, SPARKS, AND OPEN FLAMES. [√] Will not occur [ ] May occur Conditions to Avoid: N/A Incompatibility (Materials to Avoid): STRONG OXIDIZING AGENTS SUCH AS CHLORINE BLEACH AND CONCENTRATED HYDROGEN PEROXIDE; ALDEHYDES, HALOGENS, 2 of 4